Stress and immune responses after surgical treatment for regional breast cancer

Journal of the National Cancer Institute

Volumn 90, Issue 1, 1998, Pages 30-36

  Andersen, Barbara L ^a   Farrar, William B ^b   Golden Kreutz, Deanna ^a   Kutz, Leigh Ann ^b   MacCallum, Robert ^a   Courtney, Mary Elizabeth ^a   Glaser, Ronald ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT GAMMA INTERFERON; T LYMPHOCYTE RECEPTOR;

ADULT; AGED; ARTICLE; BREAST CANCER; CONTROLLED STUDY; FEMALE; HOST RESISTANCE; HUMAN; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; NATURAL KILLER CELL; POSTOPERATIVE PERIOD; SURGICAL STRESS; T LYMPHOCYTE;

EID: 0032491809     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/90.1.30     Document Type: Article

References (41)

1. Andersen BL, Anderson B, deProsse C. Controlled prospective longitudinal study of women with cancer: II. Psychological outcomes. J Consult Clin Psychol 1989;57: 692-7.
2. Moyer A, Salovey P. Psychosocial sequelae of breast cancer and its treatment. Ann Behav Med 1996;18:110-25.
3. Andersen BL. Surviving cancer. Cancer 1994;74(4 Suppl):1484-95.
4. Shalala DE (Chair). Proceedings: Secretary's Conference to Establish a National Action Plan on Breast Cancer, Dec 14-15, 1993. Bethesda (MD): National Institutes of Health, 1993.
5. Andersen BL, Kiecolt-Glaser JK, Glaser R. A biobehavioral model of cancer stress and disease course. Am Psychol 1994;49:389-404.
6. Herbert TB, Cohen S. Depression and immunity: a meta-analytic review. Psychol Bull 1993;113:472-86.
7. Herbert TB, Cohen S. Stress and immunity in humans: a meta-analytic review. Psychosom Med 1993;55:364-79.
8. Kiecolt-Glaser JK, Dura JR, Speicher CE, Trask OJ, Glaser R. Spousal caregivers of dementia victims: longitudinal changes in immunity and health. Psychosom Med 1991;53: 345-62.
9. Esterling BA, Kiecolt-Glaser JK, Bodnar JC, Glaser R. Chronic stress, social support, and persistent alterations in the natural killer cell response to cytokines in older adults. Health Psychol 1994;13:291-8.
10. Kiecolt-Glaser J., Glaser R, Gravenstein S, Malarkey WB, Sheridan J. Chronic stress alters the immune response to influenza virus vaccine in older adults. Proc Natl Acad Sci U S A 1996;93:3043-7.
11. Kiecolt-Glaser JK, Marucha PT, Malarkey WB, Mercado AM, Glaser R. Slowing of wound healing by psychological stress. Lancet 1995;346:1194-6.
12. Levy SM, Herberman RB, Lee J, Whiteside T, Kirkwood J, McFeeley S. Estrogen receptor concentration and social factors as predictors of natural killer cell activity in early-stage breast cancer patients. Confirmation of a model. Nat Immun Cell Growth Regul 1990; 9:313-24.
13. Fortner JG, Kim DK, Hopkins L, Barrett MK, Pinsky CM, Day NK. Immunologic function in patients with carcinoma of the pancreas. Surg Gynecol Obstet 1980;150:215-8.
14. Monson JR, Ramsden C, Guillou PJ. Decreased interleukin-2 production in patients with gastrointestinal cancer. Br J Surg 1986; 83:483-6.
15. Feo Figarella E, Morillo F, Blanca I, Bianco NE. Failure of cell-mediated effector mechanisms in lung cancer. J Natl Cancer Inst 1984; 73:1-6.
16. Anastasopoulos E, Reclos GJ, Baxevanis CN, Tsilivakos V, Panagiotopoulos N, Fotiou S, et. al. Monocyte disorders associated with T cell defects in cancer patients with solid tumors. Anticancer Res 1992;12:489-94.
17. Steinhauer EH, Doyle AT, Reed J, Kadish AS. Defective natural cytotoxicity in patients with cancer: normal number of effector cells but decreased recycling capacity in patients with advanced disease. J Immunol 1982;129:2255-9.
18. Jubert AV, Lee ET, Hersh EM, McBride CM. Effects of surgery, anesthesia and intraoperative blood loss on immunocompetence. J Surg Res 1973;15:399-403.
19. Herberman RB, Ortaldo JR. Natural killer cells: their roles in defenses against disease. Science 1981;241:24-30.
20. Trinchieri G. Biology of natural killer cells. Adv Immunol 1989;47:187-376.
21. Hersey P, Edwards A, Honeyman M, McCarthy WH. Low natural-killer-cell activity in familial melanoma patients and their relatives. Br J Cancer 1979;40:113-22.
22. Whiteside TL, Herberman RB. Characteristics of natural killer cells and lymphocyte-activated killer cells. Immunol Allerg Clin North Am 1990;10:663-704.
23. 2 production by monocytes is responsible for the depressed levels of natural killer and lymphokine-activated killer cell function in patients with breast cancer. Cancer 1993;72:491-501.
24. Horowitz M, Wilner N, William A. Impact of Event Scale: a measure of subjective stress. Psychosom Med 1979;41:209-18.
25. Kiecolt-Glaser JK, Glaser R. Methodological issues in behavioral immunology research with humans. Brain Behav Immun 1988;2:67-78.
26. Esterling BA, Kiecolt-Glaser JK, Glaser R. Psychosocial modulation of cytokine-induced natural killer cell activity in older adults. Psychosom Med 1996;58:264-72.
27. 3H]thymidine incorporation with MTT-and MTS-based bioassays for human and murine IL-2 and IL-4 analysis. Tetrazolium assays provide markedly enhanced sensitivity. J Immunol Methods 1995;187:85-93.
28. Shobitz B. Steroids and central regulation of immune response. Meth Neuro Sci 1994;22: 510-52.
29. Cohen J, Cohen P. Applied multiple regression/correlation analysis for the behavioral sciences. Hillsdale (NJ): Erlbaum, 1983.
30. Schedlowski M, Jacobs R, Stratmann G, Richter S, Hadicke A, Tewes U, et al. Changes in natural killer cells during acute psychological stress. J Clin Immunol 1993;13:119-26.
31. Uchino BN, Cacioppo JT, Malarkey W, Glaser R. Individual differences in cardiac sympathetic control predict endocrine and immune responses to acute psychological stress. J Pers Soc Psychol 1995;69:736-43.
32. Whiteside TL, Herberman RB. Role of human natural killer cells in health and disease. Clin Diagn Lab Immunol 1994;1:125-33.
33. Levy SM, Herberman RB, Maluish AM, Schlien B, Lippman M. Prognostic risk assessment in primary breast cancer by behavioral and immunological parameters. Health Psychol 1985;4:99-113.
34. Cannon GB, Dean JH, Herbermann RB, Perlin E, Reid J, Miller C, et al. Association of depressed postoperative lymphoproliferative responses to alloantigens with poor prognosis in patients with stage I lung cancer. Int J Cancer 1980;25:9-17.
35. Han T, Takita H. Depression of T lymphocyte response by non-T suppressor cells in lung cancer patients: a possible prognostic value of suppressor cell activity. Cancer 1979;44:2090-8.
36. Ludwig CU, Hartmann D, Landmann R, Wesp M, Rosenfelder G, Stucki D, et al. Unaltered immunocompetence in patients with non-disseminated breast cancer at the time of diagnosis. Cancer 1985;55:1673-8.
37. Baron RS, Cutrona CE, Hicklin D, Russell DW, Lubaroff DM. Social support and immune function among spouses of cancer patients. J Pers Soc Psychol 1990;59:344-52.
38. Bartrop RW, Luckhurst E, Lazarus L, Kiloh LG, Penny R. Depressed lymphocyte function after bereavement. Lancet 1977;1:834-6.
39. Locke SE, Kraus L, Leserman J, Hurst MW, Heisel JS, Williams RM. Life change stress, psychiatric symptoms, and natural killer cell activity. Psychosom Med 1984;46:441-53.
40. Kiecolt-Glaser JK, Glaser R, Williger D, Stout J, Messick G, Sheppard S, et al. Psychosocial enhancement of immunocompetence in a geriatric population. Health Psychol 1985;4: 25-41.
41. Fawzy FI, Kemeny ME, Fawzy NW, Elashoff R, Morton D, Cousins N, et al. A structured psychiatric intervention for cancer patients. II. Changes over time in immunological measures. Arch Gen Psychiatry 1990;47:729-35.